Structure |
Chemical Name |
CAS |
MF |
|
[2S-[2α(R*),3β]]-N-ForMyl- |
104872-28-8 |
C29H53NO5 |
|
7-DesMethylagoMelatine |
152302-45-9 |
C14H15NO2 |
|
2-PyriMidinaMine, 4-(4-fluoro-1-naphthalenyl)-6-(1-Methylethyl)-, Monohydrochloride |
199864-86-3 |
C17H17ClFN3 |
|
(5R)- 5-Methyl-2-Pyrrolidinone |
21395-93-7 |
C5H9NO |
|
N-[(4-Fluorophenyl)methyl]-1-methyl-4-piperidinamine |
359878-47-0 |
C13H19FN2 |
|
(S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoic acid methyl ester hydrochloride |
170098-28-9 |
C24H31NO3.HCl |
|
4a,5,9,10,11,12-hexahydro-1-bromo-3-methoxy-11-formyl-6H-benzofuro[3a,3,2-ef
][2]benzazepin-6-one |
122584-14-9 |
C17H16BrNO4 |
|
TF-BF |
209861-00-7 |
C24H22F2O5 |
|
Abacavir Carboxylate |
384380-52-3 |
C14H16N6O2 |
|
4,6-Dihydrothieno[3,4-b]thiophene-2-carboxylic acid |
7712-05-2 |
C7H6O2S2 |
|
Cefaclor, Delta-3 IsoMer |
|
|
|
3-BroMo-5fluoro-4-Methylpyridine |
1211517-76-8 |
C6H5BrFN |
|
FMoc-N-Me-Asn(trt)-OH |
941296-80-6 |
C39H34N2O5 |
|
Indacaterol interMediate |
435273-75-9 |
C31H34N2O3 |
|
3-METHYL-1,3-THIAZOLANE-2,4-DIONE |
16312-21-3 |
C4H5NO2S |
|
N-Benzoyl-5'-O-(4,4-Dimethoxytrityl)-2'-O-[(tert-butyl)dimethylsilyl]adenosine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite |
104992-55-4 |
C53H66N7O8PSi |
|
ethyl 4-(1-benzofuran-2-yl)-2,4-dioxobutanoate |
106276-58-8 |
C14H12O5 |
|
2-bromothiazol-4-amine |
41731-33-3 |
C3H3BrN2S |
|
(R)-3-Aminopentanoic acid |
131347-76-7 |
C5H11NO2 |
|
5-oxoproline, compound with piperazine (1:1) |
4889-40-1 |
C5H7NO3.C4H10N2 |
|
Tetrahydro-2-furancarboxaldehyde |
7681-84-7 |
C5H8O2 |
|
tert-butyl 4-bromo-3-(bromomethyl)thiophene-2-carboxylate |
|
|
|
Zanamivir |
139110-70-6 |
C18H26N2O10 |
|
3,5-Cyclohexadiene-1,2-dione, 4-(ethylamino)-5-methyl-, 1-oxime (9CI, ACI) |
174909-38-7 |
C9H12N2O2 |
|
1-Piperazinecarboxylic acid, 4-(1,3-dihydro-1-oxo-5-isobenzofuranyl)-, 1,1-dimethylethyl ester |
1962174-33-9 |
C17H22N2O4 |
|
Prostaglandin E synthase 3 (PTGES3) Antibody |
|
|
|
(S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4h)-trione |
110351-94-5 |
C13H13NO5 |
|
1-BENZOTHIOPHEN-3(2H)-ONE |
130-03-0 |
C8H6OS |
|
Isoquinoline, 6-(1-methylethyl)- (9CI) |
790304-84-6 |
C12H13N |
|
13,14-dihydro Prostaglandin F2a |
|
|
|
benzyl (2R,5R)-5-(hydroxymethyl)-2-methylpiperazine-1-carboxylate |
|
|
|
4(1H)-Pyrimidinone, 2-amino-5-hydroxy-6-methyl- (9CI) |
14405-13-1 |
C5H7N3O2 |
|
IRDye 680RD NHS Ester/Mal/Carboxylate/COOH |
|
|
|
Methanesulfonic anhydride |
370071-69-5 |
C8H6Br4O2 |
|
Olmesartan intermediate |
|
|
|
tert-butyl 4-[2-(2,6-dioxo-3-piperidyl)-6-fluoro-1,3-dioxo-isoindolin-5-yl]piperazine-1-carboxyl ate |
|
|
|
(1R,3R)-Methyl-1,2,3,4-tetrahydro-2-chloroacetyl-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylate |
|
C22H18ClN2O5- |
|
L-Inosine |
21138-24-9 |
C10H12N4O5 |
|
3-Morpholinecarboxylicacid,methylester,(3S)-(9CI) |
741288-31-3 |
C6H11NO3 |
|
1H-Pyrrolizine-7a(5H)-carboxylicacid,tetrahydro-,methylester(9CI) |
117375-15-2 |
C9H15NO2 |
|
5-iodo-1-(2-fluoro-2-deoxyribofuranosyl)uracil |
55612-21-0 |
C9H10FIN2O5 |
|
4-bromopyrene |
1732-26-9 |
C16H9Br |
|
ethyl 3-oxocyclopentane-1-carboxylate |
5400-79-3 |
C8H12O3 |
|
5-(Difluoromethoxy)-2[[(4-chloro-3-methoxy-2-pyridinyl)methyl]-thio]-1H-benzimidazole |
368890-20-4 |
C15H12ClF2N3O2S |
|
2-CHLORO-4-PHENYLQUINAZOLINE |
29874-83-7 |
C14H9ClN2 |
|
Morpholin-2-yl-methylamine |
116143-27-2 |
C5H12N2O |
|
3-AMINO-8-BENZYL-8-AZABICYCLO[3.2.1]OCTANE (3-EXO)- |
76272-36-1 |
C14H20N2 |
|
METHYL 4-HYDROXYMETHYLCUBANECARBOXYLATE |
60462-19-3 |
C11H12O3 |
|
(1s-trans)-2-[(phenylmethoxy)methyl]-3-cyclopenten-1-ol |
188399-48-6 |
C13H16O2 |
|
2-(2-METHOXYPHENYL)-4,4-DIMETHYL-2-OXAZOLINE |
57598-33-1 |
C12H15NO2 |
|
2,4-dimethoxybenzene-1-thiol |
18906-37-1 |
C8H10O2S |
|
7-Fluoroindole |
387-44-0 |
C8H6FN |
|
3-(4,6-dimethyl-2-oxopyrimidin-1(2H)-yl)propanoic acid |
764642-23-1 |
C9H12N2O3 |
|
3-(2-CHLORO-PHENYL)-PYRROLIDINE |
298690-74-1 |
C10H12ClN |
|
(R,R)-2,2'-(2,6-PYRIDINEDIYL)BIS(4-ISOPROPYL-2-OXAZOLINE) |
131864-67-0 |
C17H23N3O2 |
|
(r)-tert-butyl 5-methyl-1,2,3-oxathiazolidine-3-carboxylate 2,2-dioxide |
863453-61-6 |
C8H15NO5S |
|
tert-butyl (2S)-2-(hydroxymethyl)-2-methylpyrrolidine-1-carboxylate |
1339022-10-4 |
C11H21NO3 |
|
1-Pyrrolidinepropanol, β-amino-α-(2,3-dihydro-1,4-benzodioxin-6-yl)-, (αR,βR)- |
491833-28-4 |
C15H22N2O3 |
|
MK -1439 intermediate |
1155846-86-8 |
C13H6ClF3N2O2 |
|
[3,3']Biazetidinyl-1-carboxylicacidtert-butylester |
1251018-87-7 |
C11H20N2O2 |
|
1-CYCLOPROPYLPIPERAZINE DIHYDROCHLORIDE |
139256-79-4 |
C7H16Cl2N2 |
|
4,6-Dichloro-2-(4-chloro-3-fluorophenyl)pyrimidine |
1190735-18-2 |
C10H4Cl3FN2 |
|
4-(Bromomethyl)-7-(diethylamino)coumarin |
1256259-14-9 |
C14H16BrNO2 |
|
TERT-BUTYL 3-((2-ETHOXY-2-OXOETHYL)SULFONYL)AZETIDINE-1-CARBOXYLATE |
1648864-57-6 |
C12H21NO6S |
|
2-Oxo-1-benzimidazolinebutyric Acid |
3273-68-5 |
C11H12N2O3 |
|
(S)-2-(2,2,2-TRIFLUORO-ETHYL)-PIPERAZINE |
1240584-16-0 |
C6H11F3N2 |
|
1,1,1-Trifluoro-2,3-epoxypropane |
359-41-1 |
C3H3F3O |
|
2-bromo-7-propyl-[1,3,4]thiadiazolo[3,2-a]pyrimidin-5-one |
1210532-02-7 |
C8H8BrN3OS |
|
Ethyl 2-Chloro-5-fluoropyrimidine-4-carboxylate |
1246632-85-8 |
C7H6ClFN2O2 |
|
(1S,2R)-METHYL 2-(2-HYDROXYETHYL)CYCLOPROPANECARBOXYLATE |
2165933-01-5 |
C7H12O3 |
|
benzyl (S)-4-(3-((tert-butoxycarbonyl)amino)propyl)-2,5-dioxooxazolidine-3-carboxylate |
1313054-58-8 |
C19H24N2O7 |
|
1,3,5-TRIBENZYLHEXAHYDRO-1,3,5-TRIAZINE |
2547-66-2 |
C24H27N3 |
|
(R)-(+)-2-Tetrahydrofuroic acid |
87392-05-0 |
C5H8O3 |
|
methyl 3-{[(tert-butoxy)carbonyl]amino}-5-iodothiophene-2-carboxylate |
1007171-35-8 |
C11H14INO4S |
|
N1-Benzyl pseudouridine |
1613530-22-5 |
C16H18N2O6 |
|
ethyl 7-[6-[benzoyl(methyl)amino]-5-methyl-3-pyridyl]-1-cyclopropyl-8-methyl-4-oxo-quinoline-3-carboxylate |
446299-90-7 |
C30H29N3O4 |
|
6,7-dichloro-4-methyl- 2H-chromen-2-one |
923019-32-3 |
C10H6Cl2O2 |
|
3-(2-ETHOXYCARBONYL-ACETYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
877173-80-3 |
C15H25NO5 |
|
(3R,5S,2S,3S)-posaconazole |
|
|
|
tert-butyl (S)-3-(cyanomethyl)piperazine-1-carboxylate |
1589082-06-3 |
C11H19N3O2 |
|
Isoxazole |
288-14-2 |
C3H3NO |
|
methyl 2-(4-(tert-butoxycarbonyl)piperazin-1-yl)pyrimidine-5-carboxylate |
1057682-17-3 |
C15H22N4O4 |
|
tert-butyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
|
(S)-2-(2,2-difluoroethyl)piperazine |
|
|
|
(S)-2-(2,2-difluoroethyl)piperazine dihydrochloride |
|
|
|
(R)-2-(2,2,2-trifluoroethyl)piperazine dihydrochloride |
|
|
|
6-Oxo-1,6-dihydro-pyridazine-3-carboxylicacid |
37972-69-3 |
C5H4N2O3 |
|
2-phenyl-5H,6H,7H-cyclopenta[d]pyrimidin-4-ol |
87753-08-0 |
C13H12N2O |
|
△3-Cefuroxime |
|
|
|
Flomoxef Intermediate KDFA |
|
|
|
2-Methyl-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4(3H)-one |
2163770-66-7 |
C9H7F3N2OS |
|
tert-Butyl 4-iodopyrazole-1-carboxylate |
121669-70-3 |
C8H11IN2O2 |
|
Polymethylhydrosiloxane |
9004-73-3 |
C5H11OSi* |
|
Pyrroloquinoline quinone disodium salt |
122628-50-6 |
C14H4N2Na2O8 |
|
tert-butyl (S)-1-amino-4-fluoro-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
|
(3R,4S,5R)-Oseltamivir |
|
|
|
4H-Cyclopentapyrimidin-4-one, 2-chloro-1,5,6,7-tetrahydro- (9CI) |
178308-48-0 |
C7 H7 Cl N2 O |
|
(9H-fluoren-9-yl)methyl (R)-(3-(4-chlorophenyl)-1-(methylamino)-1-oxopropan-2-yl)carbamate |
|
|
|
2-CHLORO-4-METHYL-6-(TRIFLUOROMETHYL)PYRIMIDINE |
241164-09-0 |
C6H4ClF3N2 |
|
N,N,N',N'-tetrakis(2,3-epoxypropyl)cyclohexane-1,3-dimethylamine |
65992-66-7 |
C20H34N2O4 |